Linde AG (LIN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Linde AG (LIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10093
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. It offers a wide range of compressed, liquefied gases and chemicals. It also offers engineering services to petrochemical and chemical industries. The company offers medical gases and services to healthcare providers and patients in hospitals, and long term care centers. It serves various sectors including energy, steel, chemical, environmental protection, welding, food processing, glass, electronics and others. It has operations in Europe, North America, Asia Pacific, South America and Africa. Linde is headquartered in Munich, Germany.

Linde AG (LIN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Linde AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Linde AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Linde AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Linde AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Linde AG, Medical Devices Deals, 2012 to YTD 2018 9
Linde AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Linde AG, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Linde Completes Acquisition Of Homecare Business From Air Products For US$777 Million 11
Equity Offering 13
Bellerophon Therapeutics Raises USD23.4 Million in Private Placement of Units 13
Linde Announces Private Placement Of Shares For US$1.7 Billion 15
Debt Offering 16
Linde Completes Private Placement Of Notes Due 2020 For US$1.25 Billion 16
Acquisition 17
Linde To Acquire Calea France From Fresenius Kabi 17
Linde Completes Acquisition Of Lincare, Provider Of Respiratory Therapy Services, For US$4.6 Billion 18
Linde AG – Key Competitors 20
Linde AG – Key Employees 21
Linde AG – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 27
Recent Developments 28
Financial Announcements 28
Jul 25, 2018: Linde business performs well in the first half-year – significant increase in group earnings 28
Apr 25, 2018: Linde: January to March 2018: Linde makes a good start to the new year – significant increase in Group earnings 30
Corporate Communications 32
May 03, 2018: New Supervisory Board Elected At Linde AGM – Professor Dr Wolfgang Reitzle Confirmed As Chairman 32
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Linde AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Linde AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Linde AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Linde AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Linde AG, Deals By Therapy Area, 2012 to YTD 2018 8
Linde AG, Medical Devices Deals, 2012 to YTD 2018 9
Linde AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Linde Completes Acquisition Of Homecare Business From Air Products For US$777 Million 11
Bellerophon Therapeutics Raises USD23.4 Million in Private Placement of Units 13
Linde Announces Private Placement Of Shares For US$1.7 Billion 15
Linde Completes Private Placement Of Notes Due 2020 For US$1.25 Billion 16
Linde To Acquire Calea France From Fresenius Kabi 17
Linde Completes Acquisition Of Lincare, Provider Of Respiratory Therapy Services, For US$4.6 Billion 18
Linde AG, Key Competitors 20
Linde AG, Key Employees 21
Linde AG, Subsidiaries 22
Linde AG, Joint Venture 27

List of Figures
Linde AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Linde AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Linde AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Linde AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Linde AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Linde AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Linde AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Linde AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Linde AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Linde AG (LIN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Biotoscana SL (GBIO33):製薬・医療:M&Aディール及び事業提携情報
    Summary Grupo Biotoscana SL (Biotoscana) is a biopharmaceutical company that develops, manufactures and markets advanced medicines for unmet medical needs. The company offers products such as vidaza, ladevina, zyvalix, mielozitidina, votrynib, bozob, timab, enzastar, capebina, leprid, olvestran, toc …
  • CPI Aerostructures, Inc.:企業の戦略・SWOT・財務情報
    CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report Summary CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Global Marine Systems Ltd:企業の戦略的SWOT分析
    Global Marine Systems Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Reed’s, Inc.:企業の戦略・SWOT・財務分析
    Reed's, Inc. - Strategy, SWOT and Corporate Finance Report Summary Reed's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • 3M Co (MMM):医療機器:M&Aディール及び事業提携情報
    Summary 3M Company (3M) is a diversified technology company that specializes in the development, manufacture and marketing of a wide range of innovative products. The company develops technology platforms, including adhesives, abrasives, light management, microreplication, non woven materials, nanot …
  • Motorola Solutions Inc (MSI):企業の財務・戦略的SWOT分析
    Motorola Solutions Inc (MSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Change Healthcare, LLC:企業の戦略的SWOT分析
    Change Healthcare, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • MediBeacon Inc:企業の製品パイプライン分析2018
    Summary Medibeacon Inc (Medibeacon) is a provider of critical information solutions to improve patient acre. The company offers real time kidney function monitoring solutions. It offers the renal function system that helps clinicians with the continuous monitoring of the kidney. Medibeacon also prov …
  • Arlington Asset Investment Corp (AI):企業の財務・戦略的SWOT分析
    Summary Arlington Asset Investment Corp (AAIC) is an investment firm that offers asset management and investment services. The firm acquires and holds mortgage-related assets. It acquires residential mortgage-backed securities issued by the US government agencies. AAIC also acquires mortgage-backed …
  • GVC Holdings PLC:戦略・SWOT・企業財務分析
    GVC Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary GVC Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Avery Dennison Corporation (AVY)-医療機器分野:企業M&A・提携分析
    Summary Avery Dennison Corporation (Avery Dennison) is a labeling and packaging materials and solutions provider. The company produces pressure-sensitive materials, tags, labels, tickets, and other converted products. It also manufactures and sells fasteners, tickets, tags, radio-frequency identific …
  • SCANA Corporation:企業の戦略・SWOT・財務情報
    SCANA Corporation - Strategy, SWOT and Corporate Finance Report Summary SCANA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Steris PLC:企業の戦略・SWOT・財務情報
    Steris PLC - Strategy, SWOT and Corporate Finance Report Summary Steris PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • The Boeing Co (BA):企業の財務・戦略的SWOT分析
    The Boeing Co (BA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Basler Kantonalbank AG:企業の戦略・SWOT・財務情報
    Basler Kantonalbank AG - Strategy, SWOT and Corporate Finance Report Summary Basler Kantonalbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Pakistan Refinery Ltd (PRL):企業の財務・戦略的SWOT分析
    Pakistan Refinery Ltd (PRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • CiMaas BV:製薬・医療:M&Aディール及び事業提携情報
    Summary CiMaas BV (CiMaas) develops cellular immunotherapies (vaccines) for the treatment of cancer. Its pipeline cellular therapeutic products include CIM101, a dendritic cell vaccine being developed using its proprietary maturation technology for the treatment of lung cancer; and CIM201, a haploid …
  • Lidco Group Plc (LID):医療機器:M&Aディール及び事業提携情報
    Summary Lidco Group Plc (LiDCO) is a medical device company that supplies hemodynamic monitoring equipment. The company offers products such as LiDCOrapid, LiDCOunity, LiDCOplus, LiDCOview and LiDCOaccessories . Its LiDCOplus is a computer-based platform monitor, which is used in the intensive care …
  • Origin Energy Ltd (ORG)-石油・ガス分野:企業M&A・提携分析
    Summary Origin Energy Limited (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water s …
  • Citius Pharmaceuticals Inc (CTXR):製薬・医療:M&Aディール及び事業提携情報
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆